Shows
Brains Behind AIAtomwise: Abraham Heifets on how AI is redefining drug discoveryOn this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise is on the fast-track to revolutionizing the healthcare industry. Tune in to hear Atomwise’s fascinating story of how they raised $123 mill...
2023-04-1229 min
Between the Biotech WavesEpisode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of AtomwiseToday we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this recording) announced a $1.2B discovery deal with Sanofi. We discuss AI, its use in drug discovery and development, recent advances and the potential sentient nature of AI. Enjoy.
2022-09-291h 00
Practical AIDeep learning technology for drug discoveryOur Slack community wanted to hear about AI-driven drug discovery, and we listened. Abraham Heifets from Atomwise joins us for a fascinating deep dive into the intersection of deep learning models and molecule binding. He describes how these methods work and how they are beginning to help create drugs for “undruggable” diseases!Join the discussionChangelog++ members save 4 minutes on this episode because they made the ads disappear. Join today!Sponsors:O'Reilly Media – Learn by doing — Python, data, AI, machine learning, Kubernetes, Docker, and more. Just open your browser and dive in. Learn mo...
2021-03-0957 min